The 19th meeting of the Conference of the Parties (CoP19) to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) will take place from 14-25 November in Panama City. EIA encourages CITES Parties and stakeholders to consider information contained in this document when making decisions on proposals and matters in […]
Ahead of the 74th Meeting of the Standing Committee of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), EIA has prepared comments and recommendations on agenda items relating to Elephants, Pangolins, Tigers and other Asian Big Cats, Rhinos, Totoaba, Saiga, enforcement and compliance matters.
EIA has prepared analysis of the draft revision of China's Wildlife Protection Law, published for public comment in October 2020, along with recommendations for further revisions urgently needed to secure positive changes for threatened wildlife, including tigers, leopards, pangolins, elephants, rhinos and bears.
EIA research reveals that at least twenty-four Chinese pharmaceutical companies have been listing leopard bones as an ingredient in their traditional medicines, although there are fewer than 450 wild leopards left in that country.
There is no escaping the fact that countries from which wild tigers have been wiped out or virtually wiped out in recent years – Cambodia, Laos, Vietnam and China – are countries where the tiger has been valued solely for the sum of its body parts.